Funding rounds
Every row was found by Firecrawl search and extracted with a schema, with the articles behind it one click away. A check mark means its sources confirmed it.
Every row was found by Firecrawl search and extracted with a schema, with the articles behind it one click away. A check mark means its sources confirmed it.
Announced since 10 Oct 2026. Clear
| Expand | Company | Round | |||
|---|---|---|---|---|---|
A functional biology company generating decision-ready discovery data from patient-derived cells | Seed Verified against 1 of 9 sources | $5M | 2026-10-26 Oct 26 | No recent discussion | |
A U.S.-based health ingredient company developing high-purity, science-backed bioactives through precision fermentation | Series B Verified against 4 of 7 sources | $18M | 2026-10-26 Oct 26 | No recent discussion | |
Develops experimental in vivo CAR-T therapies | Pre-A Verified against 3 sources | $15.0M | 2026-10-26 Oct 26 | No recent discussion | |
Cortas offers property management services and a platform for operations, accounting, and analytics that targets property owners. | Pre-seed Verified against 4 of 19 sources | $1.6M | ~ 2026-10-26 that week | No recent discussion | |
A technical screening platform to improve recruitment for hardware companies | Pre-seed Verified against 4 of 24 sources | $2.5M | 2026-10-26 Oct 26 | No recent discussion | |
A healthcare technology innovator | Series A Verified against 4 of 53 sources | $12.8M | 2026-10-26 Oct 26 | No recent discussion | |
A developer of a healthcare administrative and workflow automation platform | Series A Verified against 4 of 8 sources | $16.3M | 2026-10-26 Oct 26 | No recent discussion | |
A remote maternal and fetal monitoring solution | Seed Verified against 2 sources | $182K | 2026-10-26 Oct 26 | No recent discussion | |
An AI agent platform designed for the financial services industry | Series B Verified against 4 of 154 sources | $56M | 2026-10-26 Oct 26 | No recent discussion | |
UV light-activated seed trait technology developer | Funding round Developing, 2 sources | $3M | ~ 2026-10-26 that week | No recent discussion | |
Spécialiste des anticorps monoclonaux | Obligations convertibles Developing, 12 sources | $448K | 2026-10-26 Oct 26 | No recent discussion | |
Health benefits tech company | Series A Verified against 1 of 31 sources | $30M | 2026-10-26 Oct 26 | No recent discussion | |
A provider of medicalforce, an all-in-one software-as-a-service (SaaS) platform for clinics | Series C Verified against 4 of 6 sources | $3.8M | 2026-10-26 Oct 26 | No recent discussion | |
An evidence-based platform for AI transformation | Seed Verified against 1 of 13 sources | $3.2M | ~ 2026-10-26 that week | No recent discussion | |
A tech-driven logistics and fulfillment platform | Seed Developing, 41 sources | not stated | 2026-10-25 Oct 25 | No recent discussion | |
Newpress offers creator-led media content, focusing on storytelling through journalism, documentaries, and interactive community engagement, primarily targeting viewers interested in independent, transparent journalism. | Funding round Verified against 4 of 8 sources | $12M | 2026-10-25 Oct 25 | No recent discussion | |
Startup de inteligência artificial voltada à mineração | Seed Developing, 10 sources | $1M | 2026-10-25 Oct 25 | No recent discussion | |
A vision AI startup that turns existing industrial CCTV into a real-time safety and operations layer | Series A Verified against 1 of 96 sources | $7.4M | 2026-10-25 Oct 25 | No recent discussion | |
A provider of an AI and simulation platform for assessing medical device performance in virtual patient populations | Series A Verified against 4 of 18 sources | $13.4M | 2026-10-25 Oct 25 | No recent discussion | |
A global fintech company building a next-generation, stablecoin-centric Financial Operating System (Financial OS) | Series C Verified against 1 of 200 sources | $40M | ~ 2026-10-24 that week | No recent discussion |
Records are extracted automatically from public reporting and link to their sources. They can contain errors. Report an error